Combined Intravitreal Methotrexate and ZR (Zanubrutinib& Rituximab) Regimen Followed by Zanubrutinib Maintenance in Newly-diagnosed Primary Vitreoretinal Lymphoma
Latest Information Update: 14 Aug 2022
At a glance
- Drugs Methotrexate (Primary) ; Rituximab (Primary) ; Zanubrutinib (Primary)
- Indications Intraocular lymphoma
- Focus Therapeutic Use
- 17 Jun 2022 Results (n=10; data cutoff date: 25 Feb 2022) presented at the 27th Congress of the European Haematology Association
- 27 May 2021 New trial record